Volume 3, Issue 1 (7-2005)                   IJRM 2005, 3(1): 25-29 | Back to browse issues page

XML Persian Abstract Print


Abstract:   (2794 Views)
Background: Pentoxifylline (PX) is a methyxanthin derivative that influences the sperm motion characteristics. In general, PX has been reportedly effective in preserving sperm motility in vitro, also when administered orally to the asthenozoospermic patients. Objective: The main objective of this prospective clinical trial study was to rule out the effect of oral administration of PX on sperm progressive motility of asthenozoospermic ejaculates obtained from men with or without mild testicular varicoceles. In addition, the role of patient�s age on sperm motility following PX administration was investigated. Materials and Methods: A total of 68 infertile men with asthenozoospermia were allocated to this study. Following physical examination, 20 cases were found with mild varicocele of testis. A dosage of 400 mg PX/ twice daily for duration of 3 months was administered to each patient. Two semen samples (one before and one after the PX therapy) were evaluated under blind condition. Semen parameters of sperm concentration, total and fast progressive motility (%) and morphology (%) were analyzed for each sample. Also, the sperm motion characteristics of asthenozoospermic patients with testicular varicocele were compared with cases lacking varicocele. The subjects were divided into two age groups of <30 and ?30 years old. Results: PX was significantly effective on the fast progressive motility of sperm (p<0.01). Also, total progressive motility was enhanced from 26.82�16.8 to 29.60�22.2 with PX therapy. However, PX did not have any negative effect on other semen parameters. Oral therapy of PX was also effective in improving the fast progressive motility of sperm of samples from cases with or without mild testicular varicocele (p<0.01). Fast progressive motility was also significantly enhanced in ejaculates of men from both age groups. Conclusion: Our results demonstrate that low dose of oral therapy of PX is significantly useful in enhancing fast progressive motility of sperms from infertile men with asthenozoospermia. Also, testicular varicocele did not interfere with enhancing effect of PX on sperm motility.
Full-Text [PDF 136 kb]   (408 Downloads) |   |   Full-Text (HTML)  (317 Views)  
Type of Study: Original Article |

References
1. Yovich JM, Edirisinghe WR, Cummins JM, Yovich JL. Influence of pentoxifylline in severe male factor infertility. Fertil Steril 1990; 53: 715-722. [DOI:10.1016/S0015-0282(16)53470-0]
2. Tournaye H, Van Steirteghem AC, Devroey P. Pentoxifylline in idiopathic male factor infertility: a review of its therapeutic efficacy after oral administration. Hum Reprod 1994; 9: 996-1000. [DOI:10.1093/oxfordjournals.humrep.a138674] [PMID]
3. Khalili MA, Vahidi S, Fallah-Zadeh, H. The effect of pentoxifylline on motility of spermatozoa from asthenozoospermic samples: fresh ejaculates, cryopreserved ejaculates, epididymal, and testicular. Mid East Fert Soc J 2001; 6: 144-151.
4. Merino G, Martinez-Chequer JC, Barahona E, Bermudez JA, Moran C. Effect of pentoxifylline on sperm motility in normogonadotrpic asthenozoospermic men. Arch Androl 1997; 39: 65-69. [DOI:10.3109/01485019708987903] [PMID]
5. Yovich JL. Pentoxifylline: actions and applications in assisted reproduction. Hum Reprod 1993; 8: 1786-1791. [DOI:10.1093/oxfordjournals.humrep.a137935] [PMID]
6. Matyas S, Papp G, Kovacs P, Balogh I, Rajczy K. Intracytoplasmic sperm injection with motile and immotile frozen-thawed testicular spermatozoa. Andrologia 2005; 37: 25-28. [DOI:10.1111/j.1439-0272.2004.00649.x] [PMID]
7. Bongso TA, Ng SC, Mok H, Lim MN, Teo HI, Wong PC. The influence of sperm motility on human in vitro fertilization. Arch Androl 1989; 22: 185-190. [DOI:10.3109/01485018908986770] [PMID]
8. Khalili MA, Vahidi S, Amir-Arjmand MA. Experimental testicular sperm extraction in rat: Pentoxifylline enhances motility (abstract). Hum Reprod 1997; 12: 121. [DOI:10.1093/humrep/12.Suppl_2.121]
9. World Health Organization. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. Cambridge Uni Press1999;128.
10. Shen MR, Chiang PH, Yang RC, Hong CY, Chen SS. Pentoxifylline stimulates human sperm motility both in vitro abd after oral therapy. Br J Clin Pharmacol 1991; 31: 711-714. [DOI:10.1111/j.1365-2125.1991.tb05600.x] [PMID] [PMCID]
11. Aparicio NJ, Schwarzstein L, de Turner EA. Pentoxifylline (BL 191) by oral administration in the treatment of asthenozoospermia. Andrologia 1980; 12: 228-231. [DOI:10.1111/j.1439-0272.1980.tb00617.x] [PMID]
12. Schill WB. Therapy of idiopathic astheno- and oligozoospermia with pentoxifylline. Fortschr Med 1982; 100: 696-700.
13. Faka B, Api M, Ficiciglu C, Gurbuz A, Oral O. Pentoxifylline in male factor infertility: its therapeutic efficacy after oral administration. Acta Eur Fertil 1994; 25: 351-353.
14. Redman JB, Carey P, Pryor JL. Varicocel- the most common cause of male factor infertility. Hum Reprod Update 2002; 8: 53-58. [DOI:10.1093/humupd/8.1.53] [PMID]
15. Pasqualotto FF, Lucon AM, de Goes PM, Hallak J, Sobreir B. Testicular growth, sperm concentration, percent motillity, and pregnancy outcome after varicocelectomy based on testicular histology. Fert Steril 2005; 83: 362-366. [DOI:10.1016/j.fertnstert.2004.06.067] [PMID]
16. Pasqualotto FF, Lucon AM, de Goes PM, Hallak J, Sobreir B. Semen profile, testicular volume, and hormonal levels in infertile patients with varicoceles compared with fertile men with and without varicoceles. Fert Steril 2005; 83: 72-78. [DOI:10.1016/j.fertnstert.2004.06.047] [PMID]
17. Eskenazi B, Wyrobek AJ, Sloter EK, Moore L, Young S, Moore D. The association of age and semen quality in healthy men. Hum Reprod 2003; 18: 447-454. [DOI:10.1093/humrep/deg107] [PMID]
18. Kumtepe Y, Yakin K, Kahraman S, Sertyel S, Vanlioglu F, Cengiz S, et al. male age is not an independent factor to affect the outcome of assisted reproductive techniques. Int J Androl 2003; 26: 161-165. [DOI:10.1046/j.1365-2605.2003.00405.x] [PMID]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.